DavidHHsiMD
Cardiology • Stamford, CTAdult Congenital Heart Disease, Cardiac Electrophysiology
Chief of Cardiology, Professor of Clinical Medicine
Dr. Hsi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
One Hospital Plaza
Stamford, CT 06904Phone+1 203-276-7405Fax+1 203-276-2376
Education & Training
Boston VA Healthcare System (Brockton-West Roxbury)Fellowship, Cardiovascular Disease, 1994 - 1995
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1992 - 1994
Newton-Wellesley HospitalResidency, Internal Medicine, 1989 - 1992
Shanghai Medical UniversityClass of 1983
Certifications & Licensure
CT State Medical License 2014 - 2025
CA State Medical License 2002 - 2020
NJ State Medical License 2010 - 2017
NY State Medical License 1995 - 2016
MA State Medical License 1991 - 2012- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2014
- Inside Jersey Magazine Top Doctors Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Join now to see all
Publications & Presentations
PubMed
- 144 citationsUltrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.Michel Azizi, Kintur Sanghvi, Manish Saxena, Philippe Gosse, John P. Reilly
Lancet. 2021-06-26 - 37 citationsEarly Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional EchocardiographyRui Zhao, Fang Shu, Chujie Zhang, Feiyan Song, Yuchen Xu
JACC. Cardiooncology. 2020-03-01 - 421 citationsEndovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trialMichel Azizi, Roland E. Schmieder, Felix Mahfoud, Michael A. Weber, Joost Daemen
Lancet. 2018-06-09
Journal Articles
- Original Investigation Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive CardiomyopathyDavid H Hsi, Martin B Leon, Shuping Ge, ScienceDirect
Press Mentions
This Hospital Is CT's First to Use AI to Detect Early Signs of Coronary Artery Disease. Here's HowOctober 26th, 2024- Roundup: Health Systems Embracing AI Imaging ToolsOctober 24th, 2024
- This Is the Best Type of Exercise if You Have a Heart Condition, According to CardiologistsOctober 15th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
